Aier Eye Hospital Group is world's leading hospital network in eye care, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of October 2017, Aier Eye Hospital Group has established more than 200 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 4 million outpatient visits annually. Recently, There are more than 80 ophthalmic branches in the United States, Europe and Hongkong.
Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.
Base on constant exploration and practice, also with absorb advanced international medical management experience, Aier Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country.
In 2013, Aier and Central South University jointly set up Aier School of ophthalmology, CSU, to educate and train medical professionals with advanced degrees; Once again in 2014, Aier joined the Hubei University of Science and Technology to establish the Aier School of Ophthalmology